We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $404M
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+28.4%
3 Year Est. Return
+72.33%
5 Year Est. Return
+90.54%
10 Year Est. Return
+313.33%
AUM
$262M
AUM Growth
+$98.6M
Cap. Flow
+$84.7M
Cap. Flow %
32.32%
Top 10 Hldgs %
30.44%
Holding
187
New
46
Increased
125
Reduced
4
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 23.77%
2 Miscellaneous 22.75%
3 Technology 14.01%
4 Industrials 11.17%
5 Consumer Staples 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
51
Biogen
BIIB
$31.9B
$1.61M 0.61%
5,415
+2,464
+83% +$684K
CME icon
52
CME Group
CME
$98.9B
$1.57M 0.6%
7,842
+2,434
+45% +$499K
CVS icon
53
CVS Health
CVS
$121B
$1.44M 0.55%
19,419
+9,126
+89% +$641K
BKNG icon
54
Booking.com
BKNG
$129B
$1.42M 0.54%
17,300
+6,050
+54% +$475K
LHX icon
55
L3Harris
LHX
$46.5B
$1.26M 0.48%
6,392
+2,099
+49% +$421K
ORCL icon
56
Oracle
ORCL
$424B
$1.24M 0.47%
23,446
+6,926
+42% +$381K
STT icon
57
State Street
STT
$50.9B
$1.24M 0.47%
15,712
+3,513
+29% +$247K
BIDU icon
58
Baidu
BIDU
$30.8B
$1.23M 0.47%
9,733
+3,537
+57% +$402K
PYPL icon
59
PayPal
PYPL
$46B
$1.23M 0.47%
11,335
+3,566
+46% +$372K
LMT icon
60
Lockheed Martin
LMT
$123B
$1.21M 0.46%
3,099
+560
+22% +$215K
VCSH icon
61
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.4B
$1.12M 0.43%
13,825
+8,200
+146% +$664K
FLO icon
62
Flowers Foods
FLO
$1.3B
$1.12M 0.43%
51,352
+8,224
+19% +$179K
CERN
63
DELISTED
Cerner Corp
CERN
$1.11M 0.42%
15,158
+4,459
+42% +$308K
MDT icon
64
Medtronic
MDT
$120B
$1.09M 0.42%
9,621
+2,781
+41% +$305K
ANET icon
65
Arista Networks
ANET
$243B
$1.07M 0.41%
84,480
+18,240
+28% +$240K
COP icon
66
ConocoPhillips
COP
$170B
$1.03M 0.39%
15,881
+5,850
+58% +$344K
ZBH icon
67
Zimmer Biomet
ZBH
$18.8B
$1.03M 0.39%
7,105
+2,141
+43% +$296K
BND icon
68
Vanguard Total Bond Market
BND
$161B
$998K 0.38%
11,902
+6,412
+117% +$539K
NTRS icon
69
Northern Trust
NTRS
$32.7B
$996K 0.38%
9,384
+2,495
+36% +$255K
NOC icon
70
Northrop Grumman
NOC
$75.5B
$994K 0.38%
2,891
+78
+3% +$27.4K
VEU icon
71
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
$974K 0.37%
+18,129
New +$942K
INTU icon
72
Intuit
INTU
$88B
$969K 0.37%
3,701
+1,006
+37% +$263K
CVX icon
73
Chevron
CVX
$427B
$914K 0.35%
7,591
+3,066
+68% +$361K
ADP icon
74
Automatic Data Processing
ADP
$110B
$906K 0.35%
5,319
+517
+11% +$85.6K
AGN
75
DELISTED
Allergan plc
AGN
$891K 0.34%
4,664
+2,470
+113% +$446K

Similar funds

Roberts, Glore & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Roberts, Glore & Co held 187 positions worth $262M, up 60% from $163M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Roberts, Glore & Co deployed $84.7M of net new capital in Q4 2019, opening 46 new positions and adding to 125 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 18,129 shares worth $974K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Linde, an estimated $68.7K trimmed.

  • Roberts, Glore & Co's largest Q4 2019 buy was Vanguard FTSE All-World ex-US ETF: 18,129 shares worth $974K.
  • Roberts, Glore & Co added most to Abbott in Q4 2019, an estimated $6.14M increase.
  • Roberts, Glore & Co's biggest Q4 2019 reduction was Linde, cutting an estimated $68.7K.
  • Roberts, Glore & Co fully exited Berkshire Hathaway Class B in Q4 2019, selling an estimated $9.69M.
  • Roberts, Glore & Co's ten largest holdings make up 30% of its $262M portfolio in Q4 2019.
  • Roberts, Glore & Co opened 46 new positions and closed 12 in Q4 2019.
  • Roberts, Glore & Co's portfolio value rose 60% quarter-over-quarter to $262M.

Based on Roberts, Glore & Co's 13F filing for Q4 2019, filed 13 Feb 2020.